Definium Therapeutics

New York, United States

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Jun 2026

Post-IPO Equity

Biotechnology Health Care Pharmaceutical Therapeutics

Top Investors

Janus Henderson InvestorsGreat Point PartnersCIBCAlly Bridge GroupCommodore Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Definium Therapeutics

Who are Definium Therapeutics's investors?

Definium Therapeutics's investors include Janus Henderson Investors, Great Point Partners, CIBC, Ally Bridge Group, Commodore Capital.

Where is Definium Therapeutics headquartered?

Definium Therapeutics is headquartered in New York, United States.

What does Definium Therapeutics do?

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

What stage is Definium Therapeutics at?

Definium Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 23, 2026.

MLA

"Definium Therapeutics — Funding & Investors." VCBacked, June 23, 2026, https://www.vcbacked.co/company/definium-therapeutics. Accessed June 30, 2026.

APA

VCBacked. (2026). Definium Therapeutics — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/definium-therapeutics

Wikipedia (cite web)

{{cite web |title=Definium Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/definium-therapeutics |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 23, 2026.